A notable study investigated Epimedium prenylflavonoids (EP), compounds derived from the plant Epimedium, known for their potential in osteoporosis treatment due to their ability to modulate TRAF6—a crucial mediator in osteoclastogenesis and bone resorption pathways. Here, TRAF6 is linked to osteoporosis.